Analysis of Mother-to-Infant Transmission of Hepatitis C Virus: Quasispecies Nature and Buoyant
Analysis of Mother-to-Infant Transmission of Hepatitis C Virus: Quasispecies Nature and Buoyant
Mother-to-infant transmission of hepatitis C vi- blood donors have a history of transfusion. On the
rus (HCV) was analyzed by sequencing of viral other hand, at least 35% of adult patients infected with
RNA and semiquantitative polymerase chain re- HCV have no identifiable source [A-Kader and Balis-
action following ultracentrifugation of maternal treri, 1993].
sera. In two mother-infant pairs, the hypervari- Several authors [Inoue et al., 1991; Thaler et al.,
able region 1 (HVR1) and carboxyl terminus of 1991; Nagata et al., 1992; Kuroki et al., 1993; Meisel et
envelope 1 (E1) were sequenced. Both viral se- al., 1995] have reported on mother-to-infant transmis-
quences in the infants were less diverse than sion of HCV. The transmission rate seems to be 5–10%
those of their mothers. Although the E1 se- if the mothers are infected with HCV alone [Ohto et al.,
quences were almost identical in each mother- 1994; Ni et al., 1994; Giacchino et al., 1995]. Coinfec-
infant pair, the HVR1 sequences of the infants
tion with human immunodeficiency virus (HIV) is
were related, but not identical, to those of the
known to increase the transmission rate of HCV
mothers. Serial examinations of one infant re-
[Zanetti et al., 1995]. Maternal viral load has been re-
vealed that the HVR1 nucleotide sequence did
not change from 10 days to 3 months of age. In ported to correlate with the risk of transmission [Ohto
six mothers with uninfected infants, all of the et al., 1994], although the exact mechanism of mother-
dense fractions of sera contained significant to-infant transmission of HCV has not yet been clari-
amounts of HCV RNA, whereas in six mothers fied.
with infected infants, only two of those fractions The N-terminal region of the putative envelope pro-
contained significant amounts of HCV RNA. tein 2 (E2) of HCV shows marked variability in nucleo-
These results indicate that the strains of HCV de- tide and deduced amino acid sequences. This region
tected in the infants were not dominant in the has been designated hypervariable region 1 (HVR1)
mothers, but were still transmissible to the in- [Hijikata et al., 1991]. Analyses of the HVR1 have in-
fants. As dense fractions are known to contain dicated that multiple subpopulations of HCV exist in a
antibody-bound HCV particles, maternal anti- chronically infected patient [Tanaka et al., 1992], and
bodies against HCV may inhibit viral transmis- these multiple subpopulations are termed quasispecies
sion. J. Med. Virol. 51:225–230, 1997. [Domingo et al., 1985]. The formation of quasispecies is
© 1997 Wiley-Liss, Inc. influenced by the host humoral immune response [Ku-
mar et al., 1994; Kudo et al., 1995], and tentative neu-
KEY WORDS: flaviviridae; vertical transmis- tralizing antibodies are thought to play an important
sion; sequencing of viral RNA; role in their formation [Kato et al., 1993; Yamaguchi et
differential flotation centrifuga- al., 1994; Yoshioka et al., 1996].
tion Recently, HCV has been reported to form immune
complexes in the sera of chronically infected patients,
and ultracentrifugation studies suggest that the den-
sities of the circulating viral particles become higher if
INTRODUCTION
Reverse transcription Polymerase Chain Cloning and Sequencing of the PCR Products
Reaction (PCR) Viral sequences were analyzed in the 38 region of
The PCR assay for detecting the 58 noncoding region envelope 1 (E1) and the 58 region of envelope 2/non-
of HCV was carried out as described previously [Shi- structural 1 region (E2/NS1) (Fig. 1). The target region
bata et al., 1991]. In brief, total RNA was extracted was amplified once, and the products were cloned fol-
from 100 ml of serum by a modified acid-guanidine- lowing purification by agarose gel-electrophoresis and
phenol-chloroform method [Chomczynski and Sacchi, ligation to the plasmid vector pCR (Stratagene, La
1987] and dissolved in 7 ml of RNase-free water. cDNA Jolla, CA). Recombinant clones were identified by re-
was synthesized using avian myeloblastosis virus re- striction enzyme digestion, and purified plasmids were
verse transcriptase (BRL, Gaithersberg, MD) in a 20 ml subjected to DNA sequencing. Thirty cycles of a cycle-
reaction mixture. The cDNA was amplified by 40 cycles sequencing reaction were carried out using Dye-primer
of thermal reaction (consisting of denaturation for 1 (ABI, Tokyo) or Dye-terminator (ABI, Tokyo), both
minute at 94°C, annealing for 2 minutes at 55°C, and based on the dideoxynucleotide chain termination
extension for 3 minutes at 72°C). A 10 ml aliquot of the method [Sanger et al., 1977]. The reaction products
amplified PCR product was subjected to agarose gel were ethanol precipitated and analyzed by a 373A DNA
electrophoresis and stained with ethidium bromide. Af- sequencer (ABI, Tokyo). Sequences were analyzed us-
ter transferring to a nylon membrane, the DNA was ing Genetyx (6.2.0) and Homology (2.2.2) software
hybridized with an alkaline phosphatase labeled inter- packages (S.D.C., Tokyo). HCV-BK was selected as a
Mechanisms of Vertical Transmission of HCV 227
TABLE I. Characteristics of HCV-Infected Mothers and Semiquantitation of HCV RNA in Fractionated Sera
Maternal history Mode Quantity Signal of HCV RNA
of of Breast- of
Case no. transfusion delivery feeding HCV RNAa Top fraction Bottom fraction
A. Mothers with Infected Infants
1 + Vaginal + 1.1 + +
2 − Vaginal + 1.3 − +
3 + C-section − <0.5 + +
4 − Vaginal − <0.5 − +
5 − Vaginal − 2.1 − ++
6 − Vaginal − 7.9 + ++
B. Mothers with Uninfected Infants
7 − Vaginal + <0.5 + ++
8 unknown Vaginal + 16.0 + ++
9 − Vaginal + <0.5 − ++
10 − C-section + 3.1 + ++
11 + Vaginal − 1.5 − ++
12 − Vaginal + 2.9 + ++
a
Assayed by bDNA method (Meq/ml [mega equivalents/ml]).
reference sequence, with base numbers 1295–1481 boxyl terminus of the E1 region showed significant ho-
used as a control for E1, and base numbers 1482–1562 mology between the mother and infant. Sequences
for the HVR1. from both cases were distinct from other HCV se-
quences reported in the GenBank, including HCV-BK,
Genotyping of HCV RNA which was selected as a reference (Table II).
Genotyping was carried out as described previously In contrast, each pair showed marked differences in
by Okamoto et al. [1992], and the results were reported the HVR1, which is adjacent to the carboxyl terminus
according to the method of Simmonds et al. [1993]. of E1, in both nucleotide and deduced amino acid se-
quences.
Differential Flotation Centrifugation
Differential flotation centrifugation was carried out Serial Examination of the HVR1 in One Infant
according to the methods described originally by Havel Serial examinations of the HVR1 in the infant from
et al. [1955] as modified by Hijikata et al. [1993]. case 3 showed no changes in nucleic and amino acid
Twenty microliters of each serum sample were loaded sequences until the infant was 5 months old, when al-
on 1 ml of a sodium chloride solution with a density of terations were observed in two nucleic acids, and in the
1.063 g/ml, and were centrifuged in a Beckman two deduced amino acids (Fig. 2). His anti-HCV titers
TLA100.4 rotor at 139500g for 22 hours at 14°C. Fol- had fallen from birth until 5 months of age, when they
lowing centrifugation, 100 ml of the top and bottom began to rise (data not shown).
fractions were collected, and assayed both by PCR to
detect HCV RNA semiquantitatively and by refracto- Comparison of the Densities of Circulating
metry to determine the respective densities. Virus in Maternal Sera
the circulation. This is consistent with the observation Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Naito M,
Kasahara A, Fusamoto H, Kamada T (1994): Buoyant density of
that the dominant populations of maternal virus were hepatitis C virus recovered from infected hosts: Two features in
not transmitted. sucrose equilibrium density-gradient centrifugation related to de-
Two mothers with infected infants showed high lev- gree of liver inflammation. Hepatology 19:296–302.
els of HCV RNA in the bottom fractions of their sera. Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Oshita M,
Katayama K, Kasahara A, Fusamoto H, Kamada T (1995a): Serial
This suggests not only that the density of circulating density analysis of hepatitis C virus particle populations in
virus is a key factor in transmission, but that other chronic hepatitis C patients treated with interferon-a. Journal of
factors probably play a role as well. Medical Virology 46:230–237.
Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Naito M,
In Table I, two of six mothers of infected infants and Kasahara A, Fusamoto H, Kamada T (1995b): Density analysis of
five of six mothers of uninfected infants have breast- hepatitis C virus particle population of infected hosts: Implica-
fed. In our recent series, however, there was no signifi- tions for virus neutralization or persistence. Journal of Hepatology
22:440–448.
cant difference in the rates of breast-fed infants be-
Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata N, Ohkoshi S,
tween those who are infected and those who are not (4 Shimotohno K (1993): Humoral immune response to hypervariable
[50%] of 8 infected infants were breast-fed, and 56 region 1 of putative envelope glycopratein (gp70) of hepatitis C
[73%] of 77 uninfected infants were breast-fed P 4 .18, virus. Journal of Virology 67:3923–3930.
Fisher’s exact test, unpublished data). Breast-feeding Kudo T, Morishima T, Shibata M, Miwata M, Matsushima M, Tsuzuki
K (1995): Low humoral responses to hepatitis C virus among pe-
did not seem to affect mother-to-infant transmission of diatric renal transplant recipients. Acta Paediatrica 84:677–682.
HCV, although breast milk was supposed to contain Kuhn L, Stein ZA (1995): Mother-to-infant HIV transmission: Timing,
antiviral components which interfere with mother-to- risk factors and prevention. Paediatric and Perinatal Epidemiol-
ogy 9:1–29.
infant transmission of HIV [Van de Perre et al., 1993].
Kumar U, Monjardino J, Thomas HC (1994): Hypervariable region of
Routes of mother-to-infant transmission of HCV are hepatitis C virus envelope glycoprotein (E2/NS1) in an agamma-
not yet well defined. Our case 3 infant was abdominally globulinemic patient. Gastroenterology 106:1072–1075.
delivered and was not breast-fed, which supports the Kuroki T, Nishiguchi S, Fukuda K, Ikeoka N, Murata R, Isshiki G,
possibility of transplacental HCV transmission. How- Tomoda S, Ogita S, Monna T, Kobayashi K (1993): Vertical trans-
mission of hepatitis C virus (HCV) detected by HCV-RNA analy-
ever, further studies are required to define the timing sis. Gut (suppl) S52–S53.
of transmission [Kuhn and Stein, 1995]. Delivery is Lau JYN, Mizokami M, Ohto T, Diamond DA, Kniffen J, Davis GL
always associated with mechanical dissociation of the (1993): Discrepancy between biochemical and virological re-
sponses to interferon-a in chronic hepatitis C. Lancet 342:1208–
placenta and the uterus, which may cause a mixing of 1209.
blood between the mother and infant. Meisel H, Reip A, Faltus B, Lu M, Porst H, Wiese M, Roggendorf M,
In conclusion, virologic analysis of mother-to-infant Kruger DH (1995): Transmission of hepatitis C virus to children
transmission of HCV suggests a significant role for the and husbands by women infected with contaminated anti-D im-
munoglobulin. Lancet 345:1209–1211.
maternal humoral immune response in preventing
Miyamoto H, Okamoto H, Sato K, Tanaka T, Mishiro S (1992): Ex-
transmission of the virus. traordinary low density of hepatitis C virus estimated by sucrose
density gradient centrifugation and the polymerase chain reac-
REFERENCES tion. Journal of General Virology 73:715–718.
Nagata I, Shiraki K, Tanimoto K, Harada Y, Tanaka Y, Okada T
A-Kader HH, Balistreri WF (1993): Hepatitis C virus: Implications to (1992): Mother-to-infant transmission of hepatitis C virus. Journal
pediatric practice. Pediatric Infectious Disease Journal 12:853– of Pediatrics 120:432–434.
867.
Ni YH, Lin HH, Chen PJ, Hsu HY, Chen DS, Chang MH (1994):
Alter MJ (1994): Transmission of hepatitis C virus: Route, dose, and Temporal profile of hepatitis C virus antibody and genome in in-
titer. New England Journal of Medicine 330:784–785. fants born to mothers infected with hepatitis C virus but without
Chomczynski P, Sacchi N (1987): Single-step method of RNA isolation human immunodeficiency virus coinfection. Journal of Hepatology
by acid guanidinium thiocyanate-phenol-chloroform extraction. 20:641–645.
Analytical Biochemistry 162:156–159. Ohto H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, Kako
Domingo E, Martinez-Salas E, Sobrino F, de la Torre JC, Portela A, M, Ujiie N, Endo C, Matsui A, Okamoto H, Mishiro S, and the
Ortin J, Lopez-Galindez C, Perez-Brena P, Villanueva N, Najera Vertical Transmission of Hepatitis C Virus Collaborative Study
R, VandePol S, Steinhauer D, DePolo N, Holland J (1985): The Group (1994): Transmission of hepatitis C virus from mothers to
quasispecies (extremely heterogeneous) nature of viral RNA ge- infants. New England Journal of Medicine 330:744–750.
nome populations: Biological relevance—a review. Gene 40:1–8. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y,
Giacchino R, Picciotto A, Tasso L, Timitilli A, Sinelli N (1995): Verti- Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M (1992): Typ-
cal transmission of hepatitis C. Lancet 345:1122–1123. ing hepatitis C virus by polymerase chain reaction with type-
Havel RJ, Eder HA, Bragdon JH (1955): The distribution and chemi- specific primers: Application to clinical surveys and tracing infec-
cal composition of ultracentrifugally separated lipoproteins in hu- tious sources. Journal of General Virology 73:673–679.
man serum. Journal of Clinical Investigation 34:1345–1353. Sanger F, Nicklen S, Coulson AR (1977): DNA sequencing with chain-
Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimo- terminating inhibiters. Proceedings of the National Academy of
tohno K (1991): Hypervariable regions in the putative glycoprotein Sciences of the USA 74:5463–5467.
of hepatitis C virus. Biochemistry and Biophysics Research Com- Shibata M, Morishima T, Kudo T, Maki T, Maki S, Nagai Y (1991):
munications 175:220–228. Serum hepatitis C virus sequences in posttransfusion non-A,
Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, non-B hepatitis. Blood 77:1157–1160.
Purcell RH, Yoshikura H (1993): Equilibrium centrifugation stud- Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G,
ies of hepatitis C virus: Evidence for circulating immune com- Saeed AA, Holmes EC (1993): Sequence variability in the 58 non-
plexes. Journal of Virology 67:1953–1958. coding region of hepatitis C virus: Identification of a new virus
Hijikata M, Mizuno K, Rikihisa T, Shimizu YK, Iwamoto A, Nakajima type and restrictions on sequence diversity. Journal of General
N, Yoshikura H (1995): Selective transmission of hepatitis C virus Virology 74:661–668.
in vivo and in vitro. Archives of Virology 140:1623–1628. Tanaka T, Kato N, Nakagawa M, Ootsuyama Y, Cho MJ, Nakazawa
Inoue Y, Miyamura T, Unayama T, Takahashi K, Saito I (1991): Ma- T, Hijikata M, Ishimura Y, Shimotohno K (1992): Molecular clon-
ternal transfer of HCV. Nature 353:609. ing of hepatitis C virus genome from a single Japanese carrier:
230 Kudo et al.
Sequence variation within the same individual and among in- titis C virus variant found in an infant born to a mother with
fected individuals. Virus Research 23:39–53. multiple variants. Journal of Virology 67:4365–4368.
Thaler MM, Park CK, Landers DV, Wara DW, Houghton M, Veere- Wolinsky SM, Wike CM, Korber BTM, Hutto C, Parks WP, Rosen-
man-Wauters G, Sweet RL, Han JH (1991): Vertical transmission blum LL, Kunstman KJ, Furtado MR, Munoz JL (1992): Selective
of hepatitis C virus. Lancet 338:17–18. transmission of human immunodeficiency virus type-1 variants
Tsai JF, Jeng JE, Chang WY, Ho MS, Lin ZY, Tsai JH (1995): Circu- from mothers to infants. Science 255:1134–1137.
lating immune complexes in chronic hepatitis C. Journal of Medi-
cal Virology 46:12–17. Yamaguchi K, Tanaka E, Higashi K, Kiyosawa K, Matsumoto A, Fu-
ruta S, Hasegawa A, Tanaka S, Kohara M (1994): Adaptation of
Urdea MS, Kolberg J, Warner BD, Horn T, Clyne J, Ku L, Running JA hepatitis C virus for persistent infection in patients with acute
(1990): A novel method for the detection of hepatitis B virus in hepatitis. Gastroenterology 106:1344–1348.
human serum samples without blotting or radioactivity. In Van
Dyke K, Van Dyke R (eds): ‘‘Luminescence Immunoassay and Mo- Yoshioka K, Higashi Y, Tanaka K, Aiyama T, Takayanagi M, Oku-
lecular Applications.’’ Boca Raton, FL: CRC, pp 275–291. mura A, Iwata K, Nagai Y, Kakumu S (1996): Deficiency of anti-
Van de Perre P, Simonon A, Hitimana DG, Dabis F, Msellati P, body response to hypervarible region of hepatitis C virus in pa-
Mukamabano B, Butera JB, Van Goethem C, Karita E, Lepage P tients with chronic hepatitis C. Journal of Hepatology 24:649–657.
(1993): Infective and anti-infective properties of breastmilk from Zanetti AR, Tanzi EE, Paccagnini S, Principi N, Pizzocolo G, Caccamo
HIV-1-infected women. Lancet 341:914–918. ML, D’Amico E, Cambie G, Vecchi L, the Lombardy Study Group
Weiner AJ, Thaler MM, Crawford K, Ching K, Kansopon J, Chien DY, on Vertical HCV Transmission (1995): Mother-to-infant transmis-
Hall JE, Hu F, Houghton M (1993): A unique, predominant hepa- sion of hepatitis C virus. Lancet 345:289–291.